Sage Therapeutics, Inc. (NASDAQ:SAGE) Q3 2024 Earnings Call Transcript October 29, 2024
Sage Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.53 EPS, expectations were $-1.52.
Operator: Good afternoon. Welcome to Sage Therapeutics’ Third Quarter 2024 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section of Sage’s website at sagerx.com. This call is a property of...
